반응식
[CH2:1]([O:3][CH2:4][CH2:5][N:6]1[C:10]2[CH:11]=[CH:12][CH:13]=[CH:14][C:9]=2[N:8]=[C:7]1[NH:15][CH:16]1[CH2:21][CH2:20][N:19](CC2C=CC=CC=2)[CH2:18][CH2:17]1)[CH3:2].CO>O.[Pd].C(N(CC)CC)C.CO>[CH2:1]([O:3][CH2:4][CH2:5][N:6]1[C:10]2[CH:11]=[CH:12][CH:13]=[CH:14][C:9]=2[N:8]=[C:7]1[NH:15][CH:16]1[CH2:17][CH2:18][NH:19][CH2:20][CH2:21]1)[CH3:2]참가 물질
5
실험 절차
Combine (1-(2-ethoxyethyl)-1H-benzimidazol-2-yl)(1-benzylpiperidin-4-yl)amine (0.51 g, 1.35 mmol), 20% palladium hydroxide-on-carbon, and methanol (40 mL). Hydrogenate in a Parr apparatus at an initial pressure of 40 psi. After 24 hours, filter through celite, rinse with methanol, and evaporate invacuo to obtain a residue. Chromatograph the residue on silica gel eluting with 4% triethylamine/methanol to give the title compound: Rf =0.28 (2% triethylamine/methanol).
후처리
- filtrationfilter through celite
- washrinse with methanol
- customevaporate invacuo
- customto obtain a residue
출처 및 근거
- ORD 기록
- ord-e67b9cb3c59941e6b0d5d60505237a65
- 출처 데이터셋
- uspto-grants-1999_07
- 특허 번호
- US05922737
연결된 노트
불러오는 중…